DOCSLIB.ORG

Carcinogenesis: Failure of Resolution of Inflammation?

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Carcinogenesis: Failure of Resolution of Inflammation? Pharmacology & Therapeutics 218 (2021) 107670 Contents lists available at ScienceDirect Pharmacology & Therapeutics journal homepage: www.elsevier.com/locate/pharmthera Carcinogenesis: Failure of resolution of inflammation? Anna Fishbein a,b,⁎, Bruce D. Hammock c, Charles N. Serhan d,1, Dipak Panigrahy a,b,1 a Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA b Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA c Department of Entomology and Nematology, and UCD Comprehensive Cancer Center, University of California, Davis, CA 95616, USA d Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA article info abstract Available online 3 September 2020 Inflammation in the tumor microenvironment is a hallmark of cancer and is recognized as a key characteristic of carcinogens. However, the failure of resolution of inflammation in cancer is only recently being understood. Prod- ucts of arachidonic acid and related fatty acid metabolism called eicosanoids, including prostaglandins, leukotri- Keywords: enes, lipoxins, and epoxyeicosanoids, critically regulate inflammation, as well as its resolution. The resolution of Eicosanoid inflammation is now appreciated to be an active biochemical process regulated by endogenous specialized pro- Carcinogen resolving lipid autacoid mediators which combat infections and stimulate tissue repair/regeneration. Environ- Inflammation mental and chemical human carcinogens, including aflatoxins, asbestos, nitrosamines, alcohol, and tobacco, in- Resolution duce tumor-promoting inflammation and can disrupt the resolution of inflammation contributing to a Resolvin devastating global cancer burden. While mechanisms of carcinogenesis have focused on genotoxic activity to in- Soluble epoxide hydrolase duce mutations, nongenotoxic mechanisms such as inflammation and oxidative stress promote genotoxicity, proliferation, and mutations. Moreover, carcinogens initiate oxidative stress to synergize with inflammation and DNA damage to fuel a vicious feedback loop of cell death, tissue damage, and carcinogenesis. In contrast, stimulation of resolution of inflammation may prevent carcinogenesis by clearance of cellular debris via macro- phage phagocytosis and inhibition of an eicosanoid/cytokine storm of pro-inflammatory mediators. Controlling the host inflammatory response and its resolution in carcinogen-induced cancers will be critical to reducing carcinogen-induced morbidity and mortality. Here we review the recent evidence that stimulation of resolution of inflammation, including pro-resolution lipid mediators and soluble epoxide hydrolase inhibitors, may be a new chemopreventive approach to prevent carcinogen-induced cancer that should be evaluated in humans. © 2020 Elsevier Inc. All rights reserved. Contents 1. Introduction............................................... 2 2. InflammationandCancer......................................... 3 3. Carcinogens and inflammation....................................... 3 4. Humancarcinogens............................................ 6 5. Carcinogenesisisamulti-stage,multi-mechanismprocess.......................... 7 6. Detectionofcarcinogens.......................................... 7 7. Mechanismsofpro-tumorigenicactivitybycarcinogens........................... 8 8. Therapeuticapproaches.......................................... 14 Abbreviations: 12-O-tetradecanoylphorbol-13-acetate, TPA; 4-nitroquinaline 1-oxide, 4-NQO; 7,12-dimethylbenz[a]anthracene, DMBA; Aflatoxin B1,AFB1; Azoxymethane, AOM; benzo[a]pyrene, BaP; Dextran sodium sulfate, DSS; Diethylstilbestrol, DES; Hepatocellular carcinoma, HCC; Inducible nitric oxide synthase, iNOS; Lipopolysaccharide, LPS; Liquid chromatography-tandem mass spectrometry, LC-MS/MS; N-butyl-N-(4-hydroxybutyl)-nitrosamine, BBN; N-nitrosobis(2-oxopropyl)amine, BoP; N-nitrosodiethylamine, NDEA / Diethylnitrosamine DEN; N-nitrosodimethylamine, NDMA / Dimethylnitrosamine DMN; N-nitrosomethylbenzylamine, NMBA; Nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone, NNK; Nuclear factor erythroid-2 related factor 2, Nrf2; Perfluorinated carboxylic acids, PCFAs; Perfluorooctanoic acid, PFOA/C8; Phorbol 12-myrisate 13-acetate, PMA; Polycyclic aromatic hydrocarbons, PAHs; Soluble epoxide hydrolase, sEH; Specialized pro-resolving mediators, SPMs. ⁎ Corresponding author at: 99 Brookline Ave. Rm 220, Boston, MA 02215, USA. E-mail address: [email protected] (A. Fishbein). 1Contributed equally. https://doi.org/10.1016/j.pharmthera.2020.107670 0163-7258/© 2020 Elsevier Inc. All rights reserved. A. Fishbein, B.D. Hammock, C.N. Serhan et al. Pharmacology & Therapeutics 218 (2021) 107670 9. Outlook................................................. 23 Acknowledgments............................................... 23 DeclarationofCompetingInterest........................................ 23 References................................................... 23 1. Introduction microenvironment (Serhan, 2017; Sulciner et al., 2018). In healthy indi- viduals, the acute inflammatory response(s) is self-limited and can be Carcinogens induce inflammation, an established hallmark of cancer classically divided into initiation and resolution phases (Serhan, 2014). (Greten & Grivennikov, 2019; Hanahan & Weinberg, 2011; Mantovani, Neutrophils (polymorphonuclear leukocytes) are one of the first im- Allavena, Sica, & Balkwill, 2008). With potential exposure to greater mune cell types to enter the wounded area and remove microbes as than 15 million environmental chemicals worldwide, controlling in- well as cellular debris (Serhan & Levy, 2018). Cancer is viewed as a flammation and its resolution will be a critical component of the suc- wound that does not heal, thus attracting similar cell types and mecha- cessful prevention and treatment of cancer (Gilligan et al., 2019; nisms as wound healing and tissue regeneration (Dvorak, 1986). A par- Panigrahy et al., 2019; Sulciner et al., 2018). Uncontrolled local and sys- adigm shift is emerging in our understanding of the pathogenesis of temic hyperinflammation is an underlying driving force of diseases in- pathological inflammation which not only results from the persistent cluding cardiovascular disease (e.g. atherosclerosis and myocardial activation of inflammatory signals, but also the failure of engaging infarction), abdominal aortic aneurysm, heart arrhythmias, arthritis, pro-resolving mechanisms including clearance of cell death “debris” central nervous system disorders, periodontal disease, inflammatory and counter-regulation of pro-inflammatory cytokines (Serhan, 2014; bowel disease, gallstones, sepsis, infection, stroke/epilepsy, infection, Serhan & Levy, 2018). Experimental and human studies suggest that acute respiratory distress syndrome (ARDS), fibrosis (e.g. liver, kidney cancer progression results from the “failure to clear debris” after chemo- and lung), portal hypertension, fatty liver, neurodegenerative diseases therapy, radiation, or surgery (Chaurio et al., 2013; da Silva-Jr, (e.g. Alzheimer's disease), traumatic brain injury, asthma, obesity, dia- Chammas, Lepique, & Jancar, 2017; Ford et al., 2015; Gartung et al., betes, pain, severe coronavirus disease (e.g. COVID-19), and autoim- 2019; Gilligan et al., 2019; Gunjal et al., 2015; Huang et al., 2011; mune diseases (Chelko et al., 2019; Chiang et al., 2012; Espinoza et al., Panigrahy et al., 2019; Revesz, 1956; Sulciner et al., 2018; Ye et al., 2016; Imig & Hammock, 2009; Libby, 2002; Mehta et al., 2020; 2018). Thus, failure to engage resolution of inflammation mechanisms Serhan, 2014; Spite et al., 2009). Over the past century, the study of including clearance of debris may lead to carcinogenesis. Differentiating anti-inflammatory mechanisms has focused on the suppression of between suppression and resolution of inflammation is critical to mech- pro-inflammatory mediators, such as cytokines, eicosanoids, and en- anistic studies in inflammation-driven diseases including cancer zymes (Wang & Dubois, 2010). In recent years, a new direction has (Fishbein et al., 2020; Gilligan et al., 2019; Kuang, Hua, Zhou, & Yang, emerged to “turn off” inflammation with the discovery of a new super- 2016; Panigrahy et al., 2019; Serhan, 2014; Shan et al., 2020; Sulciner family of endogenous specialized pro-resolving lipid-autacoid media- et al., 2018); Ye et al., 2018). tors (SPMs), such as resolvins, which have potent novel inflammation A key concept in resolution of inflammation is that the immune sys- clearing (‘pro-resolution’) activity without being immunosuppressive tem can be beneficial in fighting cancer, in accordance with the increas- (Serhan, 2014; Serhan et al., 2002; Serhan et al., 2009). Unlike the ma- ing interest in immune-mediated approaches in targeting cancer jority of anti-inflammatory agents including the nonsteroidal anti- (Serhan, 2011; Sharma & Allison, 2015). In 1790 the Scottish surgeon inflammatory drugs (NSAIDs) such as celecoxib and ibuprofen that John Hunter remarked “Inflammation in itself is not to be considered work by directly suppressing cyclooxygenase (COX-2) enzyme activity, as a disease” (Turk, 1994). In 1893 William Coley successfully treated SPMs are endogenous inhibitors of inflammation, which function as sarcomas with bacterial mixtures, leading to tumor regression (Coley, “brake signals” to turn
Load more

Recommended publications
  • Chemicals in the Fourth Report and Updated Tables Pdf Icon[PDF
    Chemicals in the Fourth National Report on Human Exposure to Environmental Chemicals: Updated Tables, March 2021 CDC’s Fourth National Report on Human Exposure to Environmental Chemicals: Updated Tables, March 2021 provides exposure data on the following chemicals or classes of chemicals. The Updated Tables contain cumulative data from national samples collected beginning in 1999–2000 and as recently as 2015-2016. Not all chemicals were measured in each national sample. The data tables are available at https://www.cdc.gov/exposurereport. An asterisk (*) indicates the chemical has been added since publication of the Fourth National Report on Human Exposure to Environmental Chemicals in 2009. Adducts of Hemoglobin Acrylamide Formaldehyde* Glycidamide Tobacco Alkaloids and Metabolites Anabasine* Anatabine* Cotinine Cotinine-n-oxide* Hydroxycotinine* Trans-3’-hydroxycotinine* 1-(3-Pyridyl)-1-butanol-4-carboxylic acid* Nicotine* Nicotine-N’-oxide* Nornicotine* Tobacco-Specific Nitrosamines (TSNAs) N’-Nitrosoanabasine (NAB)* N’-Nitrosoanatabine (NAT)* N’-Nitrosonornicotine (NNN)* Total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) (NNAL)* Volatile N-nitrosamines (VNAs) N-Nitrosodiethylamine (NDEA)* N-Nitrosoethylmethylamine (NMEA)* N-Nitrosomorpholine (NMOR)* N-Nitrosopiperidine (NPIP)* N-Nitrosopyrrolidine (NPYR)* Disinfection By-Products Bromodichloromethane Dibromochloromethane Tribromomethane (Bromoform) Trichloromethane (Chloroform) Personal Care and Consumer Product Chemicals and Metabolites Benzophenone-3 Bisphenol A Bisphenol F* Bisphenol
    [Show full text]
  • DRAFT Indicators Biomonitoring: Perfluorochemicals (Pfcs)
    America’s Children and the Environment, Third Edition DRAFT Indicators Biomonitoring: Perfluorochemicals (PFCs) EPA is preparing the third edition of America’s Children and the Environment (ACE3), following the previous editions published in December 2000 and February 2003. ACE is EPA’s compilation of children’s environmental health indicators and related information, drawing on the best national data sources available for characterizing important aspects of the relationship between environmental contaminants and children’s health. ACE includes four sections: Environments and Contaminants, Biomonitoring, Health, and Special Features. EPA has prepared draft indicator documents for ACE3 representing 23 children's environmental health topics and presenting a total of 42 proposed children's environmental health indicators. This document presents the draft text, indicator, and documentation for the PFCs topic in the Biomonitoring section. THIS INFORMATION IS DISTRIBUTED SOLELY FOR THE PURPOSE OF PRE- DISSEMINATION PEER REVIEW UNDER APPLICABLE INFORMATION QUALITY GUIDELINES. IT HAS NOT BEEN FORMALLY DISSEMINATED BY EPA. IT DOES NOT REPRESENT AND SHOULD NOT BE CONSTRUED TO REPRESENT ANY AGENCY DETERMINATION OR POLICY. For more information on America’s Children and the Environment, please visit www.epa.gov/ace. For instructions on how to submit comments on the draft ACE3 indicators, please visit www.epa.gov/ace/ace3drafts/. March 2011 DRAFT: DO NOT QUOTE OR CITE Biomonitoring: Perfluorochemicals 1 Perfluorochemicals (PFCs) 2 3 Perfluorochemicals (PFCs) are a group of manmade chemicals that have been used since the 4 1950s in many consumer products.1 The structure of these chemicals makes them very stable, 5 hydrophobic (water-repelling), and oleophobic (oil-repelling).
    [Show full text]
  • And Polyfluoroalkyl Substances – Chemical Variation and Applicability of Current Fate Models
    CSIRO PUBLISHING Environ. Chem. 2020, 17, 498–508 Research Paper https://doi.org/10.1071/EN19296 Investigating the OECD database of per- and polyfluoroalkyl substances – chemical variation and applicability of current fate models Ioana C. Chelcea,A Lutz Ahrens,B Stefan O¨ rn,C Daniel MucsD and Patrik L. Andersson A,E ADepartment of Chemistry, Umea˚ University, SE-901 87 Umea˚, Sweden. BDepartment of Aquatic Sciences and Assessment, Swedish University of Agricultural Sciences (SLU), Box 7050, SE-750 07 Uppsala, Sweden. CDepartment of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences (SLU), SE-750 07 Uppsala, Sweden. DRISE SP – Chemical and Pharmaceutical Safety, Forskargatan 20, 151 36 So¨derta¨lje, Sweden. ECorresponding author. Email: [email protected] Environmental context. A diverse range of materials contain organofluorine chemicals, some of which are hazardous and widely distributed in the environment. We investigated an inventory of over 4700 organofluorine compounds, characterised their chemical diversity and selected representatives for future testing to fill knowledge gaps about their environmental fate and effects. Fate and property models were examined and concluded to be valid for only a fraction of studied organofluorines. Abstract. Many per- and polyfluoroalkyl substances (PFASs) have been identified in the environment, and some have been shown to be extremely persistent and even toxic, thus raising concerns about their effects on human health and the environment. Despite this, little is known about most PFASs. In this study, the comprehensive database of over 4700 PFAS entries recently compiled by the OECD was curated and the chemical variation was analysed in detail.
    [Show full text]
  • Pfoa) Or Perfluorooctane Sulfonate (Pfos
    National Toxicology Program NTP U.S. Department of Health and Human Services NTP Monograph Immunotoxicity Associated with Exposure to Perfluorooctanoic Acid or Perfluorooctane Sulfonate September 2016 NTP MONOGRAPH ON IMMUNOTOXICITY ASSOCIATED WITH EXPOSURE TO PERFLUOROOCTANOIC ACID (PFOA) OR PERFLUOROOCTANE SULFONATE (PFOS) September, 2016 Office of Health Assessment and Translation Division of the National Toxicology Program National Institute of Environmental Health Sciences National Institutes of Health U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Systematic Review of Immunotoxicity Associated with Exposure to PFOA or PFOS TABLE OF CONTENTS Table of Contents ...............................................................................................................................II List of Table and Figures ................................................................................................................... IV Abstract ............................................................................................................................................. 1 Peer Review Of The Draft NTP Monograph ......................................................................................... 2 Peer-Review Panel .............................................................................................................................. 2 Introduction ...................................................................................................................................... 3 Objective and Specific Aims ...............................................................................................................
    [Show full text]
  • Epigenetic Regulations of Ahr in the Aspect of Immunomodulation
    International Journal of Molecular Sciences Review Epigenetic Regulations of AhR in the Aspect of Immunomodulation Anna Wajda 1,* , Joanna Łapczuk-Roma ´nska 2 and Agnieszka Paradowska-Gorycka 1 1 Department of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland; [email protected] 2 Department of Experimental and Clinical Pharmacology, Pomeranian Medical University, 70-111 Szczecin, Poland; [email protected] * Correspondence: [email protected] Received: 31 July 2020; Accepted: 28 August 2020; Published: 3 September 2020 Abstract: Environmental factors contribute to autoimmune disease manifestation, and as regarded today, AhR has become an important factor in studies of immunomodulation. Besides immunological aspects, AhR also plays a role in pharmacological, toxicological and many other physiological processes such as adaptive metabolism. In recent years, epigenetic mechanisms have provided new insight into gene regulation and reveal a new contribution to autoimmune disease pathogenesis. DNA methylation, histone modifications, chromatin alterations, microRNA and consequently non-genetic changes in phenotypes connect with environmental factors. Increasing data reveals AhR cross-roads with the most significant in immunology pathways. Although study on epigenetic modulations in autoimmune diseases is still not well understood, therefore future research will help us understand their pathophysiology and help to find new therapeutic strategies. Present literature review
    [Show full text]
  • Cross-Sectional Study of the Association Between Serum Perfluorinated Alkyl Acid Concentrations and Dental Caries Among US Adolescents (NHANES 1999–2012)
    Open access Research BMJ Open: first published as 10.1136/bmjopen-2018-024189 on 5 February 2019. Downloaded from Cross-sectional study of the association between serum perfluorinated alkyl acid concentrations and dental caries among US adolescents (NHANES 1999–2012) Nithya Puttige Ramesh,1 Manish Arora,2 Joseph M Braun1 To cite: Puttige Ramesh N, ABSTRACT Strengths and limitations of this study Arora M, Braun JM. Cross- Study objectives Perfluoroalkyl acids (PFAAs) are a class sectional study of the of anthropogenic and persistent compounds that may ► Our study contributes to a gap in the literature by association between serum impact some biological pathways related to oral health. perfluorinated alkyl acid examining the relationship between perfluoroalkyl The objective of our study was to estimate the relationship concentrations and dental caries acid exposure and dental caries prevalence among between dental caries prevalence and exposure to four among US adolescents (NHANES adolescents, which, to the best of our knowledge, PFAA: perfluorooctanoic acid (PFOA), perfluorononanoic 1999–2012). BMJ Open has not been examined before. 2019;9:e024189. doi:10.1136/ acid (PFNA), perfluorohexane sulfonic acid (PFHxS) and ► The strengths of our study include the large sample perfluorooctane sulfonic acid (PFOS) in a nationally bmjopen-2018-024189 size (2869 participants) and the nationally repre- representative sample of US adolescents. Prepublication history and sentative nature of the National Health and Nutrition ► Setting/Design We analysed cross-sectional data from additional material for this Examination Survey (NHANES). the National Health and Nutrition Examination Survey from paper are available online. To ► Although we adjusted for potential confounders, 1999 to 2012 for 12–19-year-old US adolescents.
    [Show full text]
  • PFAS MCL Technical Support Document
    ATTACHMENT 1 New Hampshire Department of Environmental Services Technical Background Report for the June 2019 Proposed Maximum Contaminant Levels (MCLs) and Ambient Groundwater Quality Standards (AGQSs) for Perfluorooctane sulfonic Acid (PFOS), Perfluorooctanoic Acid (PFOA), Perfluorononanoic Acid (PFNA), and Perfluorohexane sulfonic Acid (PFHxS) And Letter from Dr. Stephen M. Roberts, Ph.D. dated 6/25/2019 – Findings of Peer Review Conducted on Technical Background Report June 28, 2019 New Hampshire Department of Environmental Services Technical Background Report for the June 2019 Proposed Maximum Contaminant Levels (MCLs) and Ambient Groundwater Quality Standards (AGQSs) for Perfluorooctane sulfonic Acid (PFOS), Perfluorooctanoic Acid (PFOA), Perfluorononanoic Acid (PFNA), and Perfluorohexane sulfonic Acid (PFHxS) June 28, 2019 Table of Contents Abbreviations ................................................................................................................................................. i Acknowledgements ...................................................................................................................................... iii Section I. Executive Summary ....................................................................................................................... 1 Section II. Introduction ................................................................................................................................. 2 Section III. Reference Dose Derivation ........................................................................................................
    [Show full text]
  • Environmental Pollution 275 (2021) 116665
    Environmental Pollution 275 (2021) 116665 Contents lists available at ScienceDirect Environmental Pollution journal homepage: www.elsevier.com/locate/envpol Metabolomics reveals the reproductive abnormality in female zebrafish exposed to environmentally relevant levels of climbazole* Ting Zou a, 1, Yan-Qiu Liang b, 1, Xiaoliang Liao a, Xiao-Fan Chen a, Tao Wang c, * Yuanyuan Song c, Zhi-Cheng Lin a, Zenghua Qi a, Zhi-Feng Chen a, d, , Zongwei Cai a, c a Guangdong Key Laboratory of Environmental Catalysis and Health Risk Control, School of Environmental Science and Engineering, Institute of Environmental Health and Pollution Control, Guangdong University of Technology, Guangzhou, 510006, China b Faculty of Chemistry and Environmental Science, Guangdong Ocean University, Zhanjiang, 524088, China c State Key Laboratory of Environmental and Biological Analysis, Department of Chemistry, Hong Kong Baptist University, Hong Kong Special Administrative Region, China d Guangdong Provincial Key Laboratory of Chemical Pollution and Environmental Safety, South China Normal University, Guangzhou, 510006, China article info abstract Article history: Climbazole (CBZ) ubiquitously detected in the aquatic environment may disrupt fish reproductive Received 15 November 2020 function. Thus far, the previous study has focused on its transcriptional impact of steroidogenesis-related Received in revised form genes on zebrafish, but the underlying toxic mechanism still needs further investigation at the metabolic 10 January 2021 level. In this study, adult zebrafish were chronically exposed to CBZ at concentrations of 0.1 (corre- Accepted 2 February 2021 sponding to the real concentration in surface water), 10, and 1000 mg/L and evaluated for reproductive Available online 5 February 2021 function by egg production, with subsequent ovarian tissue samples taken for histology, metabolomics, and other biochemical analysis.
    [Show full text]
  • Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome
    International Journal of Molecular Sciences Review Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome Stefano Turolo 1,* , Alberto Edefonti 1 , Alessandra Mazzocchi 2, Marie Louise Syren 2, William Morello 1, Carlo Agostoni 2,3 and Giovanni Montini 1,2 1 Fondazione IRCCS Ca’ Granda-Ospedale Maggiore Policlinico, Pediatric Nephrology, Dialysis and Transplant Unit, Via della Commenda 9, 20122 Milan, Italy; [email protected] (A.E.); [email protected] (W.M.); [email protected] (G.M.) 2 Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy; [email protected] (A.M.); [email protected] (M.L.S.); [email protected] (C.A.) 3 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Pediatric Intermediate Care Unit, 20122 Milan, Italy * Correspondence: [email protected] Abstract: Studies concerning the role of arachidonic acid (AA) and its metabolites in kidney disease are scarce, and this applies in particular to idiopathic nephrotic syndrome (INS). INS is one of the most frequent glomerular diseases in childhood; it is characterized by T-lymphocyte dysfunction, alterations of pro- and anti-coagulant factor levels, and increased platelet count and aggregation, leading to thrombophilia. AA and its metabolites are involved in several biological processes. Herein, Citation: Turolo, S.; Edefonti, A.; we describe the main fields where they may play a significant role, particularly as it pertains to their Mazzocchi, A.; Syren, M.L.; effects on the kidney and the mechanisms underlying INS. AA and its metabolites influence cell Morello, W.; Agostoni, C.; Montini, G.
    [Show full text]
  • Journal of Carcinogenesis Biomed Central
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central Journal of Carcinogenesis BioMed Central Editorial Open Access New paradigms, new Hopes: the need for socially responsible research on carcinogenesis Gopala Kovvali* Address: Gopala Kovvali Ph.D. Editor-in-Chief, Journal of Carcinogenesis, Founder President, Carcinogenesis Foundation, 22 Heritage Drive, Edison, NJ 08820, USA Email: Gopala Kovvali* - [email protected] * Corresponding author Published: 21 November 2005 Received: 15 November 2005 Accepted: 21 November 2005 Journal of Carcinogenesis 2005, 4:22 doi:10.1186/1477-3163-4-22 This article is available from: http://www.carcinogenesis.com/content/4/1/22 © 2005 Kovvali; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. It has been three years since the publication of the first The formation of the Carcinogenesis Foundation is a his- article in the Journal of Carcinogenesis; it was the editorial toric opportunity. While its goal is to promote and that espoused the need for the launch of the journal. Hav- advance research in the field of carcinogenesis, it has a ing seen three springs and three falls, it is time to ask specialized mission of understanding the phenomenon of where we are as a journal and where we want to be in the increased cancer incidence among individuals who years to come. migrate to the western countries.
    [Show full text]
  • Lipoxin A4: a Novel Anti-Inflammatory Molecule? Thorax: First Published As 10.1136/Thx.50.2.111 on 1 February 1995
    Thorax 1995;50:111-112 illl Lipoxin A4: a novel anti-inflammatory molecule? Thorax: first published as 10.1136/thx.50.2.111 on 1 February 1995. Downloaded from Arachidonic acid is metabolised by the cyclooxygenase contractions.22 These studies support the view that LXA4 pathway to the prostaglandins and thromboxane A2 or via may act as a partial agonist at the same or similar site as one of the lipoxygenase pathways.' Three major lip- the sulphidopeptide leukotrienes. oxygenase pathways have been identified in mammalian The fact that 1 5-lipoxygenase is abundant in lung tissue tissue - namely, the 5-, 12-, and 15-lipoxygenases.2A The and that LXA4 has been recovered in the bronchoalveolar 5-lipoxygenase pathway metabolises arachidonic acid lavage fluid ofpatients with asthma and other lung diseases through two intermediates, 5-hydroperoxyeicosatetranoic suggests that LXA4 may be a potential mediator or mod- acid (5-HPETE) and leukotriene A4 (LTA4), to LTB4 and ulator of inflammation in the lung. In a recent study eight the sulphidopeptide leukotrienes LTC4, LTD4, and LTE4.5 subjects underwent inhalation challenge with LXA4,23 but The sulphidopeptide leukotrienes are potent spasmogens6 no effect was seen on specific conductance, rate of airflow for non-vascular smooth muscle and may play a part in at 25% vital capacity (V25), blood pressure, pulse, or the pathogenesis of bronchial asthma.7`10 asthmatic symptoms. There was, however, a significant The interactions between 5-lipoxygenase and 15-lip- shift of the specific conductance and V25 dose-response oxygenase on arachidonic acid metabolism have recently curve to the right after inhalation challenge with LTC4 been studied and a new series of biologically active me- combined with LXA4 compared with that after inhalation tabolites described." 12 These molecules have been termed challenge with LTC4 alone.
    [Show full text]
  • Regulation of Immune Cells by Eicosanoid Receptors
    Regulation of Immune Cells by Eicosanoid Receptors The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Kim, Nancy D., and Andrew D. Luster. 2007. “Regulation of Immune Cells by Eicosanoid Receptors.” The Scientific World Journal 7 (1): 1307-1328. doi:10.1100/tsw.2007.181. http://dx.doi.org/10.1100/ tsw.2007.181. Published Version doi:10.1100/tsw.2007.181 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:37298366 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Review Article Special Issue: Eicosanoid Receptors and Inflammation TheScientificWorldJOURNAL (2007) 7, 1307–1328 ISSN 1537-744X; DOI 10.1100/tsw.2007.181 Regulation of Immune Cells by Eicosanoid Receptors Nancy D. Kim and Andrew D. Luster* Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston E-mail: [email protected] Received March 13, 2007; Revised June 14, 2007; Accepted July 2, 2007; Published September 1, 2007 Eicosanoids are potent, bioactive, lipid mediators that regulate important components of the immune response, including defense against infection, ischemia, and injury, as well as instigating and perpetuating autoimmune and inflammatory conditions. Although these lipids have numerous effects on diverse cell types and organs, a greater understanding of their specific effects on key players of the immune system has been gained in recent years through the characterization of individual eicosanoid receptors, the identification and development of specific receptor agonists and inhibitors, and the generation of mice genetically deficient in various eicosanoid receptors.
    [Show full text]